Product logins

Find logins to all Clarivate products below.


Matthew Jewkes

SVP and Head of AI Product Transformation

Matthew Jewkes is SVP and Head of AI Product Transformation at Clarivate. In this role, Matth ew is broadly responsible for the development of proprietary Artificial Intelligence platform capabilities, Artificial Intelligence guidance and advisory, and transformative Artificial Intelligence applications in Clarivate products and services, focusing on Life Sciences & Healthcare.

Matthew joined Clarivate through its acquisition of MotionHall, where he was co-founder and CTO. At MotionHall, he oversaw the development of proprietary technology and guided the development of a comprehensive digital twin of the global biopharmaceutical industry. This model leverages terabytes of proprietary industry data, massively indexed public data sets, and worked on proprietary deep learning neural networks as well as other computational methodologies.

Matthew has led at the forefront of multiple significant transitions in software, from introduction of the iPhone to advanced cryptographic methods, and now the rapidly emerging capabilities of AI technologies.

He is a strong advocate for corporate social responsibility, customer success and employee success and a champion for the benefit of our customers and the patients they serve.

Matthew studied Computer Science at Dalhousie University.

Latest news

News September 4, 2025
Clarivate to Present at the Goldman Sachs Communacopia + Technology Conference on September 11

London, UK – September 4, 2025, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will…

News September 1, 2025
16th Annual Clarivate Pharmavision India Conference to Address Market Shifts, Innovation and Global Access

2025 event to explore how Indian pharmaceutical companies can capture new growth in generics and biosimilars while navigating competition and regulatory complexities London, U.K. September 1, 2025: Clarivate Plc (NYSE:CLVT),…

News August 27, 2025
Sinopec Group Selects Clarivate for Impactful Research and Innovation

New Partnership Delivers Web of Science and incoPat Solutions to China’s Leading Energy Company   London, U.K. August 27, 2025: Clarivate Plc (NYSE: CLVT), a leading provider of transformative intelligence,…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025